These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8849761)

  • 1. Validity of immunological faecal occult blood screening for colorectal cancer: a follow up study.
    Nakama H; Kamijo N; Abdul Fattah AS; Zhang B
    J Med Screen; 1996; 3(2):63-5. PubMed ID: 8849761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme.
    Itoh M; Takahashi K; Nishida H; Sakagami K; Okubo T
    J Med Screen; 1996; 3(2):66-71. PubMed ID: 8849762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
    Nakama H; Kamijo N
    Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study to evaluate efficacy of screening for faecal occult blood.
    Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
    J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Faecal occult blood test and mass screening for colorectal cancer].
    Hiwatashi N; Shimada T
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():201-6. PubMed ID: 14574882
    [No Abstract]   [Full Text] [Related]  

  • 7. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.
    Saito H
    J Med Screen; 2006; 13 Suppl 1():S6-7. PubMed ID: 17227634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new immunological test strip device for the rapid, qualitative detection of faecal occult blood.
    Trojan J; Povse N; Schröder O; Stein J
    Z Gastroenterol; 2002 Nov; 40(11):921-4. PubMed ID: 12436369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of colorectal cancer with false negative result on immunochemical faecal occult blood test.
    Nakama H; Kamijo N; Fujimori K; Horiuchi A; Fattah AS; Zhang B
    J Med Screen; 1996; 3(3):115-8. PubMed ID: 8946304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort.
    Chen LS; Yen AM; Chiu SY; Liao CS; Chen HH
    Lancet Oncol; 2011 Jun; 12(6):551-8. PubMed ID: 21592859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme.
    Castiglione G; Visioli CB; Ciatto S; Grazzini G; Bonanomi AG; Rubeca T; Mantellini P; Zappa M
    Br J Cancer; 2007 Jun; 96(11):1750-4. PubMed ID: 17453007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric cancer after positive screening faecal occult blood testing and negative assessment.
    Zappa M; Visioli CB; Ciatto S; Grazzini G; Rubeca T; Bonanomi AG; Confortini M; Paci E; Castiglione G
    Dig Liver Dis; 2007 Apr; 39(4):321-6. PubMed ID: 17314076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
    Malila N; Hakama M; Pukkala E
    Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
    Jansen JB; van Rossum LG; Laheij RJ
    Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of systematic false-negative test results on the performance of faecal occult blood screening.
    Loeve F; Boer R; van Oortmarssen GJ; van Ballegooijen M; Habbema JD
    Eur J Cancer; 2001 May; 37(7):912-7. PubMed ID: 11313180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient factors associated with non-attendance at colonoscopy after a positive screening faecal occult blood test.
    Plumb AA; Ghanouni A; Rainbow S; Djedovic N; Marshall S; Stein J; Taylor SA; Halligan S; Lyratzopoulos G; von Wagner C
    J Med Screen; 2017 Mar; 24(1):12-19. PubMed ID: 27216771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
    Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M
    Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.